• November 5, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, Dec. 2, in New York, N.Y. Paul Herendeen, Executive Vice President and Chief Financial Officer, and Dr. Catherine Knupp, Executive Vice President and President, Research and Development, will represent the company and respond to questions from analysts. They are scheduled to present at 8:30 a.m. EST. Investors and other interestedmore...
  • November 4, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the third quarter of 2014. The company reported revenue of $1.2 billion for the third quarter of 2014, an increase of 10% from the third quarter of 2013. Revenue reflected an operational2 increase of 10%, with foreign currency having no material impact on revenue growth this quarter. Net income for the third quarter of 2014 was $166 million, or $0.33 per dilutedmore...
  • October 27, 2014
    PARIS, FRANCE - October 27, 2014 – A new European research centre, comprising a collaborative network of veterinarians, scientists and technical specialists with a coordinating hub in Edinburgh, Scotland, aims to identify emerging diseases in livestock and companion animals, and enhance the ability to control them.This centre of excellence is a collaboration between the Easter Bush Research Consortium (EBRC) and global animal health company Zoetis.  This collaboration forms a part ofmore...
  • October 16, 2014
    SHANGHAI, CHINA – Oct. 15, 2014 – Zoetis Inc. and Nestlé today announced an agreement in which Zoetis will develop the educational curriculum for the Dairy Farming Institute (DFI) in Shuangcheng, Heilongjiang Province in Northeast China.Zoetis will bring to the Institute and its partner organizations veterinary medical and technical expertise. The company will leverage its veterinary and dairy producer relationships to advance the work of the Institute in helping China’s dairy farmers meet themore...
  • October 2, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--The Board of Directors of Zoetis Inc. (NYSE:ZTS) declared a fourth quarter dividend payable to holders of the company’s common stock of $0.072 per share. The dividend is to be paid on Tuesday, Dec. 2, 2014, to holders of record on Wednesday, Nov. 5, 2014. About Zoetis Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 yearsmore...
  • September 30, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) will host a webcast and conference call at 8:30 a.m. (EST) on Tuesday, November 4, 2014. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Paul Herendeen will review third quarter 2014 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Zoetis website at httpmore...
  • September 25, 2014
    FLORHAM PARK, NJ, Sept. 25, 2014 — Zoetis now offers a test to quickly and accurately screen for the detection of antibodies to Johne’s Disease in cattle, the company announced today.Matthew Krecic, DVM, MS, MBA, DACVIM, Senior Technical Services Manager of U.S. Diagnostics, Zoetis, said the test uses an indirect immunoenzymatic technique to detect Mycobacterium avium, subspecies paratuberculosis (M. ParaTB) antibodies in samples of cattle serum and plasma. Results are available in less thanmore...
  • September 16, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that it has been named among the top 10 on Working Mother magazine’s "100 Best Companies for Working Mothers" list. The publication selects the top 100 companies in the U.S. that have demonstrated their commitment to progressive workplace programs such as child care, flexibility, advancement and paid family leave. “Zoetis is honored to be named one of Working Mother magazine’s top tenmore...
  • September 3, 2014
    FLORHAM PARK, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Department of Agriculture (USDA) has granted a conditional license for a vaccine to help fight porcine epidemic diarrhea virus (PEDv) in pigs. The two-dose inactivated vaccine, licensed for use in healthy pregnant female pigs (sows and gilts), is designed to help them develop antibodies which can be transmitted to their newborn piglets. Zoetis anticipates the vaccine will be available tomore...
  • August 27, 2014
    DURHAM, N.C., August 27, 2014 – Zoetis Inc. has obtained a full license from the U.S. Department of Agriculture (USDA) to sell Poulvac® Bron GA 08, the first commercially available vaccine to reduce disease caused by Georgia 2008 (GA 08) Type infectious bronchitis virus (IBV) in poultry.Poulvac® Bron GA 08, a live vaccine, is licensed for vaccination of healthy chickens at one day of age or older as an aid in the reduction of disease caused by GA 08. The vaccine was licensed based on clinicalmore...